Page last updated: 2024-10-26

ethosuximide and Inflammatory Bowel Diseases

ethosuximide has been researched along with Inflammatory Bowel Diseases in 1 studies

Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Picard, E1
Carvalho, FA1
Agosti, F1
Bourinet, E1
Ardid, D1
Eschalier, A1
Daulhac, L1
Mallet, C1

Other Studies

1 other study available for ethosuximide and Inflammatory Bowel Diseases

ArticleYear
Inhibition of Ca
    British journal of pharmacology, 2019, Volume: 176, Issue:7

    Topics: Animals; Benzeneacetamides; Calcium Channel Blockers; Calcium Channels, T-Type; Colon; Dextran Sulfa

2019